MAPT and Down syndrome: It is noteworthy, that changes in the APP and tau processing have also been described in Down’s syndrome (Lee et al., 2016), while tau alterations have been detected in a wide range of neurodegenerative disorders collectively called tauopathies (Williams, 2006), as well as in aging (Wharton et al., 2016).